Paul Sax, MD
May 23rd, 2012
Panel: Azithromycin and Cardiovascular Risk
Paul Sax, MD, Joseph S. Ross, MD, MHS and Jeffrey Lance Anderson, MD
Three experts offer perspective on a large database study showing an association between azitrhromycin use and increased risk for cardiovascular death.
NEJM Journal Watch — Recent Cardiology Articles- Atrial Fibrillation and Stable Coronary Artery Disease — What Is the Optimal Anticoagulation–Antiplatelet Regimen?
- β-Blockers After Myocardial Infarction
- Updated Guideline for Perioperative Cardiovascular Management of Patients Undergoing Noncardiac Surgery
- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?